CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
| Address | 5505 Endeavor Lane Madison, Wisconsin 53719 |
| Phone | +1.608.284.5700 |
| Number of Employees | 1,977 |
| Recent SEC Filing | 08/08/2022 3 |
| Chairman, President & Chief Executive Officer | Kevin T. Conroy |
| Executive VP, Chief Operating & Financial Officer | Jeffrey Thomas Elliott |
| Senior VP-Clinical & Regulatory Affairs | Sandra Statz |
| Chief Information Officer | Gary Frings |
| Price Open | $42.65 |
| Previous Close | $42.36 |
| 52 Week Range | $35.34 - 108.99 |
| Market Capitalization | $7.6 B |
| Shares Outstanding | 177.0 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 11/01/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$4.13 |
| Beta vs. S&P 500 | N/A |
| Revenue | $454.5 M |
| Net Profit Margin | -37.89% |
| Return on Equity | -22.07% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
